MR imaging and PET/CT in diagnosis and management of multiple myeloma
(©)RSNA, 2015..
Multiple myeloma is a common hematologic malignancy among the elderly population. Although there have been many advances in treatment over the past few decades, the overall prognosis for the disease remains poor. Conventional radiography has long been the standard of reference for the imaging of multiple myeloma. However, 10%-20% of patients with multiple myeloma do not have evidence of disease at conventional radiography. There is a growing body of evidence supporting use of magnetic resonance (MR) imaging and 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in diagnosis and management of multiple myeloma. MR imaging is useful in detection of bone marrow infiltration, a finding often missed at conventional radiography. FDG PET/CT is especially sensitive for the detection of extramedullary disease and can help detect the metabolically active lesions that often precede evidence of osseous destruction at conventional radiography. MR imaging and FDG PET/CT are useful tools that can provide essential information for diagnosis and management of patients with multiple myeloma. Both modalities allow accurate localization of disease after chemotherapy or autologous stem cell transplantation and can provide important prognostic information that can influence further clinical decision making regarding therapy, particularly when tumor serum markers may be a less reliable indicator of disease burden after repeated treatments.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Radiographics : a review publication of the Radiological Society of North America, Inc - 35(2015), 2 vom: 12. März, Seite 438-54 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ferraro, Regan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.01.2016 Date Revised 10.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1148/rg.352140112 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM247011959 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM247011959 | ||
| 003 | DE-627 | ||
| 005 | 20231224144312.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1148/rg.352140112 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0823.xml |
| 035 | |a (DE-627)NLM247011959 | ||
| 035 | |a (NLM)25763728 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferraro, Regan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MR imaging and PET/CT in diagnosis and management of multiple myeloma |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.01.2016 | ||
| 500 | |a Date Revised 10.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a (©)RSNA, 2015. | ||
| 520 | |a Multiple myeloma is a common hematologic malignancy among the elderly population. Although there have been many advances in treatment over the past few decades, the overall prognosis for the disease remains poor. Conventional radiography has long been the standard of reference for the imaging of multiple myeloma. However, 10%-20% of patients with multiple myeloma do not have evidence of disease at conventional radiography. There is a growing body of evidence supporting use of magnetic resonance (MR) imaging and 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in diagnosis and management of multiple myeloma. MR imaging is useful in detection of bone marrow infiltration, a finding often missed at conventional radiography. FDG PET/CT is especially sensitive for the detection of extramedullary disease and can help detect the metabolically active lesions that often precede evidence of osseous destruction at conventional radiography. MR imaging and FDG PET/CT are useful tools that can provide essential information for diagnosis and management of patients with multiple myeloma. Both modalities allow accurate localization of disease after chemotherapy or autologous stem cell transplantation and can provide important prognostic information that can influence further clinical decision making regarding therapy, particularly when tumor serum markers may be a less reliable indicator of disease burden after repeated treatments | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Agarwal, Ankit |e verfasserin |4 aut | |
| 700 | 1 | |a Martin-Macintosh, Erica L |e verfasserin |4 aut | |
| 700 | 1 | |a Peller, Patrick J |e verfasserin |4 aut | |
| 700 | 1 | |a Subramaniam, Rathan M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Radiographics : a review publication of the Radiological Society of North America, Inc |d 1993 |g 35(2015), 2 vom: 12. März, Seite 438-54 |w (DE-627)NLM013031619 |x 1527-1323 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2015 |g number:2 |g day:12 |g month:03 |g pages:438-54 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1148/rg.352140112 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2015 |e 2 |b 12 |c 03 |h 438-54 | ||